Septic Shock and Septic Shock Mortality in Relation to Social Disorganization Index Among Children Being Treated for De Novo Acute Myeloid Leukemia on COG Clinical Trials. Read more about Septic Shock and Septic Shock Mortality in Relation to Social Disorganization Index Among Children Being Treated for De Novo Acute Myeloid Leukemia on COG Clinical Trials.
High Incidence and Mortality of Invasive Fungal Disease in Children and Young Adults with Hematologic Malignancies in Hawaii and Pacific Islands. Read more about High Incidence and Mortality of Invasive Fungal Disease in Children and Young Adults with Hematologic Malignancies in Hawaii and Pacific Islands.
Financial Coping Strategies and Financial Assistance Following a Pediatric Hematologic Malignancy. Read more about Financial Coping Strategies and Financial Assistance Following a Pediatric Hematologic Malignancy.
Profiling the Cell Surface of MPN Blast Phase Suggests Unique Biology and Therapeutic Targets. Read more about Profiling the Cell Surface of MPN Blast Phase Suggests Unique Biology and Therapeutic Targets.
Structural Elements of the BCR Determine Permissiveness to Oncogenic RAS-Driven B-Cell Transformation. Read more about Structural Elements of the BCR Determine Permissiveness to Oncogenic RAS-Driven B-Cell Transformation.
BCL6-Mediated Escape from Negative Selection Enables RAS-Driven B-Cell Transformation. Read more about BCL6-Mediated Escape from Negative Selection Enables RAS-Driven B-Cell Transformation.
A Phosphatase Membrane-Shuttle Enables Feedback Control of B-Cell Signaling. Read more about A Phosphatase Membrane-Shuttle Enables Feedback Control of B-Cell Signaling.
Structural Surfaceomics Reveals an AML-Specific Conformation of Integrin-ß2 As an Immunotherapeutic Target. Read more about Structural Surfaceomics Reveals an AML-Specific Conformation of Integrin-ß2 As an Immunotherapeutic Target.
Integrating Transcriptomics and Proteomics for the Discovery of Novel Antigen Targets on Surface of Malignant Plasma Cells Amenable for Chimeric Antigen Receptor-T (CAR-T) Cell Approach in the Treatment of Patients with Relapsed/Refractory Multiple Myelom Read more about Integrating Transcriptomics and Proteomics for the Discovery of Novel Antigen Targets on Surface of Malignant Plasma Cells Amenable for Chimeric Antigen Receptor-T (CAR-T) Cell Approach in the Treatment of Patients with Relapsed/Refractory Multiple Myelom
Humanized Nanobody Anti-CD72 CAR-T Cells Efficiently Eliminate B-Cell Malignancies Via Improved Affinity for CD72 but Induce Persistent Antigen Downregulation In Vivo. Read more about Humanized Nanobody Anti-CD72 CAR-T Cells Efficiently Eliminate B-Cell Malignancies Via Improved Affinity for CD72 but Induce Persistent Antigen Downregulation In Vivo.
